Compare RDY & BWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | BWA |
|---|---|---|
| Founded | 1984 | 1987 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 11.2B |
| IPO Year | 2001 | 1995 |
| Metric | RDY | BWA |
|---|---|---|
| Price | $12.97 | $52.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 16 |
| Target Price | $16.90 | ★ $57.88 |
| AVG Volume (30 Days) | ★ 2.1M | 1.9M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | 0.54% | ★ 1.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.28 |
| Revenue | N/A | ★ $14,316,000,000.00 |
| Revenue This Year | $7.81 | $1.64 |
| Revenue Next Year | $3.20 | $3.53 |
| P/E Ratio | ★ $18.67 | $42.02 |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $12.82 | $25.92 |
| 52 Week High | $16.17 | $70.08 |
| Indicator | RDY | BWA |
|---|---|---|
| Relative Strength Index (RSI) | 36.35 | 44.88 |
| Support Level | $12.93 | $51.19 |
| Resistance Level | $14.14 | $56.23 |
| Average True Range (ATR) | 0.25 | 1.38 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 11.16 | 13.43 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2024, 23% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.